chevron-down Created with Sketch Beta.
September 02, 2021

University of Pittsburgh Medical Center Launches Drug Development Company

UPMC recently launched Novasenta, a drug discovery and development company. The company focuses on developing novel and effective treatments for cancer in the tumor microenvironment, based on years of research performed by University of Pittsburgh scientists. UPMC, through its innovation and venture capital arm UPMC Enterprises, contributed an initial seed round investment of $20 million. Novasenta is the third local life science start-up developed in collaboration between the University of Pittsburgh and UPMC Enterprises over the last four years.